Biomarker T Cell dalam Diagnosis COVID-19 : Literatur Review
Downloads
Latar Belakang : COVID-19 menjadi masalah kesehatan didunia. Penanda inflamasi yang dapat digunakan sebagai predictor prognosis COVID-19. Tujuan untuk melihat peran biomarker sel T pada penyakit COVID-19. Metode: Pencarian literatur utama PubMed dan Cinahl untuk artikel yang diterbitkan antara Tahun 2015 hingga 2021 dan telah memenuhi syarat, artikel dipilih setelah evaluasi judul, abstrak, dan referensi. Sebanyak 7 artikel termasuk dalam ulasan ini. Hasil: Analisis artikel ini ditemukan faktor sel T limfosit yang berperan dalam biomarker dalam diagnosis COVID-19 adalah CD4+, CD8+ dan CD3+ dan hasil yang meningkat secara signifikant adalah CD8+. Kesimpulan: Analisis artikel menunjukkan bahwa ada bukti yang jelas bahwa biomarker Limfosit T dapat berubah sesuai dengan tingkat keparahan Infeksi COVID-19. Ini dapat digunakan sebagai tambahan dalam praktik klinis. Â
Downloads
Shanmugaraj B, Siriwattananon K, Wangkanont K, Phoolcharoen W. Perspectives on monoclonal antibody therapy as potential therapeutic intervention for Coronavirus disease-19 (COVID-19). Asian Pacific J Allergy Immunol. 2020;38(1):10–8.
Krajewska J, Krajewski W, Zub K, Zatoński T. COVID-19 in otolaryngologist practice: a review of current knowledge. Eur Arch Oto-Rhino-Laryngology. 2020;277(7):1885–97.
Hu X, Deng Y, Wang J, Li H, Li M, Lu Z. Short term outcome and risk factors for mortality in adults with critical Severe Acute Respiratory Syndrome (SARS). J Huazhong Univ Sci Technol - Med Sci. 2004;24(5):514–7.
Booth TF, Kournikakis B, Bastien N, Ho J, Kobasa D, Stadnyk L, et al. Detection of airborne severe acute respiratory syndrome (SARS) coronavirus and environmental contamination in SARS outbreak units. J Infect Dis. 2005;191(9):1472–7.
Jain N, Varman R, Tarbox JA, Nguyen T. Biomolecular endotype factors involved in COVID-19 airway infectivity: A systematic review. Auris Nasus Larynx. 2021;48(1):32–40.
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506.
Zaim S, Chong JH, Sankaranarayanan V, Harky A. COVID-19 and Multiorgan Response. Curr Probl Cardiol. 2020;45(8):100618.
Pierce JD, McCabe S, White N, Clancy RL. Biomarkers: An important clinical assessment tool. Am J Nurs. 2012;112(9):52–8.
Wang D, Li R, Wang J, Jiang Q, Gao C, Yang J, et al. Correlation analysis between disease severity and clinical and biochemical characteristics of 143 cases of COVID-19 in Wuhan, China: A descriptive study. BMC Infect Dis. 2020;20(1):1–9.
Portney LG. Foundations of Clinical Research: Applications to Evidence-Based Practice. Foundations of Clinical Research: Applications to Evidence-Based Practice, 4e. 2020. 913 p.
Catanzaro M, Fagiani F, Racchi M, Corsini E, Govoni S, Lanni C. Immune response in COVID-19: addressing a pharmacological challenge by targeting pathways triggered by SARS-CoV-2. Signal Transduct Target Ther. 2020;5(1).
dyznski Moderbacher RC, Ramirez SI, Dan JM, Grifoni A, Hastie KM, Weiskopf D, et al. Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity. Cell. 2020;183(4):996–1012.e19.
Sánchez-Cerrillo I, Landete P, Aldave B, Sánchez-Alonso S, Sánchez-Azofra A, Marcos-Jiménez A, et al. COVID-19 severity associates with pulmonary redistribution of CD1c+ DCs and inflammatory transitional and nonclassical monocytes. J Clin Invest. 2020 Dec;130(12):6290–300.
Files JK, Boppana S, Perez MD, Sarkar S, Lowman KE, Qin K, et al. Sustained cellular immune dysregulation in individuals recovering from SARS-CoV-2 infection. J Clin Invest. 2021 Jan;131(1).
Gao M, Liu Y, Guo M, Wang Q, Wang Y, Fan J, et al. Regulatory CD4(+) and CD8(+) T cells are negatively correlated with CD4(+) /CD8(+) T cell ratios in patients acutely infected with SARS-CoV-2. J Leukoc Biol. 2021 Jan;109(1):91–7.
Zeng Z, Hong X-Y, Li Y, Chen W, Ye G, Li Y, et al. Serum-soluble ST2 as a novel biomarker reflecting inflammatory status and illness severity in patients with COVID-19. Biomark Med. 2020 Dec;14(17):1619–29.
Jiang M, Guo Y, Luo Q, Huang Z, Zhao R, Liu S, et al. T-Cell Subset Counts in Peripheral Blood Can Be Used as Discriminatory Biomarkers for Diagnosis and Severity Prediction of Coronavirus Disease 2019. J Infect Dis. 2020 Jul;222(2):198–202.
Varchetta S, Mele D, Oliviero B, Mantovani S, Ludovisi S, Cerino A, et al. Unique immunological profile in patients with COVID-19. Cell Mol Immunol. 2021 Mar;18(3):604–12.
Li CK, Wu H, Yan H, Ma S, Wang L, Zhang M, et al. T Cell Responses to Whole SARS Coronavirus in Humans. J Immunol. 2008;181(8):5490–500.
Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical Characteristics of 138 Hospitalized Patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA - J Am Med Assoc. 2020;323(11):1061–9.
Cecere TE, Todd SM, LeRoith T. Regulatory T cells in arterivirus and coronavirus infections: Do they protect against disease or enhance it? Viruses. 2012;4(5):833–46.
Deng Z, Zhang M, Zhu T, Zhili N, Liu Z, Xiang R, et al. Dynamic changes in peripheral blood lymphocyte subsets in adult patients with COVID-19. Int J Infect Dis. 2020;98:353–8.
Wu F, Zhao S, Yu B, Chen YM, Wang W, Song ZG, et al. A new coronavirus associated with human respiratory disease in China. Nature. 2020;579(7798):265–9.
Diao B, Wang C, Tan Y, Chen X, Liu Y, Ning L, et al. Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19). Front Immunol. 2020;11(May):1–7.
Zheng M, Gao Y, Wang G, Song G, Liu S, Sun D, et al. Functional exhaustion of antiviral lymphocytes in COVID-19 patients. Cell Mol Immunol. 2020;17(5):533–5.
Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020;8(4):420–2.
Li D, Chen Y, Liu H, Jia Y, Li F, Wang W, et al. Immune dysfunction leads to mortality and organ injury in patients with COVID-19 in China: insights from ERS-COVID-19 study. Signal Transduct Target Ther. 2020;5(1):8–10.
